The link between drinking water arsenic, blood pressure, and stroke risk.
Drinking Water Arsenic, Blood Pressure, and Ischemic Stroke in the REGARDS Study
This study is looking at how drinking water with arsenic might affect blood pressure and the chances of having a stroke, and it's for people from all walks of life across the U.S. who want to understand the health risks linked to arsenic in their water.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11013666 on NIH RePORTER |
What this research studies
This research investigates how exposure to arsenic in drinking water may affect blood pressure and the risk of ischemic stroke among participants in the REGARDS Study, which includes a diverse group of individuals from across the United States. By integrating various data sources, including water quality data and health outcomes, the study aims to uncover potential health impacts related to arsenic exposure. The research will analyze differences in responses based on factors such as sex and race, providing a comprehensive understanding of the issue.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals from the REGARDS Study, particularly those living in areas with known arsenic contamination in drinking water.
Not a fit: Patients who do not consume drinking water from sources with arsenic contamination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved public health recommendations and interventions to reduce stroke risk associated with arsenic exposure in drinking water.
How similar studies have performed: Previous research has shown associations between drinking water contaminants and health outcomes, suggesting that this approach could yield valuable insights.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Gribble, Matthew O. — University of California, San Francisco
- Study coordinator: Gribble, Matthew O.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.